Inogen (NASDAQ:INGN). is a medical technology company specializing in the design, manufacture and distribution of oxygen therapy solutions for patients with chronic respiratory conditions. The company’s primary offerings include a family of portable oxygen concentrators (POCs) and home oxygen concentrators (HOCs), engineered to provide continuous and pulse flow oxygen delivery. Inogen’s products are designed to enhance patient mobility, allowing users to maintain active lifestyles while receiving prescribed oxygen therapy.
Founded in 2001 and headquartered in Goleta, California, Inogen has established a global footprint through direct sales, rental channels and partnerships with home healthcare providers. The company operates manufacturing facilities in California and distributes its devices across North America, Europe, and selected markets in Asia and Latin America. Inogen’s portable concentrators, known for their lightweight design and long-lasting battery life, have become a standard of care in many home and outpatient settings.
Under the leadership of its executive team, Inogen continues to invest in research and development to advance portable oxygen technology. The company’s interdisciplinary R&D group focuses on improving device efficiency, reducing overall weight, extending battery performance and integrating smart monitoring features. Inogen also collaborates with clinicians, therapists and patient advocacy organizations to ensure its products address real-world patient needs and regulatory requirements.
Looking ahead, Inogen remains committed to broadening its product portfolio and expanding patient access to oxygen therapy. The company is exploring new models and accessory solutions that support telehealth integration, remote patient monitoring and customizable oxygen delivery profiles. Through ongoing innovation and a dedication to quality standards, Inogen aims to deliver safe, reliable and user-friendly oxygen therapy for patients worldwide.
